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Homozygous staggerermice (sg/sg) display decreased anddys-
functional retinoic acid receptor-related orphan receptor 
(ROR) expression.We observed decreases in serum (and liver)
triglycerides and total and high density lipoprotein serum cho-
lesterol in sg/sgmice. Moreover, the sg/sgmice were character-
ized by reduced adiposity (associated with decreased fat pad
mass and adipocyte size). Candidate-based expression profiling
demonstrated that the dyslipidemia in sg/sg mice is associated
with decreased hepatic expression of SREBP-1c, and the reverse
cholesterol transporters,ABCA1 andABCG1. This is consistent
with the reduced serum lipids. The molecular mechanism did
not involve aberrant expression of LXR and/or ChREBP. How-
ever, ChIP and transfection analyses revealed that ROR is
recruited to and regulates the activity of the SREBP-1c pro-
moter. Furthermore, the lean phenotype in sg/sg mice is also
characterized by significantly increased expression of PGC-1,
PGC-1, and lipin1mRNA in liver andwhite andbrownadipose
tissue from sg/sg mice. In addition, we observed a significant
4-fold increase in 2-adrenergic receptor mRNA in brown adi-
pose tissue. Finally, dysfunctional ROR expression protects
against diet-induced obesity. Following a 10-week high fat diet,
wild-type but not sg/sg mice exhibited a 20% weight gain,
increased hepatic triglycerides, and notable white and brown
adipose tissue accumulation. In summary, these changes in gene
expression (that modulate lipid homeostasis) in metabolic tis-
sues are involved in decreased adiposity and resistance to diet-
induced obesity in the sg/sg mice, despite hyperphagia. In con-
clusion, we suggest this orphan nuclear receptor is a key
modulator of fat accumulation and that selective ROR modula-
tors may have utility in the treatment of obesity.
The spontaneously arising mouse mutant, staggerer (sg),4
was initially described and analyzed several decades ago (1).
The homozygous mice display ataxia, cerebellar defects,
tremor, and imbalance. Subsequently, the gene encoding reti-
noic acid receptor-related orphan receptor  (ROR) (2, 3) was
mapped to mouse chromosome 9 in the immediacy of the sg
locus (4, 5). ROR is an orphanmember of the nuclear receptor
superfamily (6). Several studies have identified cholesterol sul-
fate (and derivatives) as potential ligands for this nuclear recep-
tor (7, 8), however, further studies are required to resolve this
issue.
The sgmutation has been shown to be an intragenic deletion
in the coding region ofROR, removing an exondownstreamof
the DNA binding domain (4, 5). This results in a frameshift
mutation that affects the co-expressed isoforms ROR1 and
-4 (5).ROR transcript levels are significantly reduced in stag-
gerer (sg/sg) mice, and it has been clearly demonstrated that the
sg phenotype is associated with the expression of dysfunctional
ROR (9). Moreover, ROR-deficient mice display many
aspects of the staggerer phenotype (9, 10).
Mamontova et al. (11) demonstrated that male and female
homozygous staggerer (sg/sg) are characterized by hypo--
lipoproteinemia and decreased serum cholesterol (total and
high density lipoprotein (HDL)) consequent to reduced apo-
lipoprotein A-I (apoA1) expression in the intestine, but not
in liver. Previously, Vu Dac et al. (12) established that apoA1
is directly regulated by ROR1-mediated trans-activation.
Moreover, sg/sgmice are susceptible to atherosclerosis on an
atherogenic diet (11). These studies indicated that ROR is
involved in the regulation of lipoprotein homeostasis in
mice. Subsequently, Raspe et al. (13), showed that female
sg/sg mice have reduced plasma triglycerides, coupled to
concordant decreases in apolipoprotein C-III (apoCIII)
mRNA expression in liver and (proximal and distal) intes-
tine. In this context a study from our laboratory, using an in
vitro skeletal muscle cell culture model, demonstrated that
overexpression of ROR1 (lacking the ligand binding
domain) results in reduced sterol regulatory element-bind-
ing transcription factor 1, isoform c (SREBP-1c) mRNA
expression (14). These studies have underscored the perti-
nent role of ROR in lipid homeostasis.
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ROR is abundantly expressed in the liver and the other
major mass peripheral metabolic tissues. Moreover, sg/sgmice
consume an increased amount of food (per gram bodyweight),
but, despite this feeding pattern, they maintain a lower weight
(15, 16). Surprisingly, no studies have investigated this aspect of
the staggerer phenotype. Hence, we were particularly inter-
ested in elucidating the functional role of ROR in the control
of genes that regulate lipogenesis and fatty acid oxidation in
liver, skeletal muscle, and white adipose tissues in homozygous
sg/sgmice.We hypothesized, based on our in vitro studies, that
SREBP-1cmay be a critical component in themetabolic pheno-
type of sg/sgmice.
We observed that sg/sg mice displayed an early onset
decrease inweight that wasmaintained aftermaturity and asso-
ciated with decreased adiposity. Themice (expressing dysfunc-
tional ROR) displayed reduced serum and hepatic lipids, con-
sistent with decreased ATP-binding cassette, subfamily A,
member 1 (ABCA1), ATP-binding cassette, subfamily G, mem-
ber 1 (ABCG1), SREBP-1c, and fatty acid synthase (FAS)mRNA
expression in the liver. ChIP and transfection analyses showed
that ROR mediated trans-activation of the SREBP-1c pro-
moter. Candidate-based expression profiling in sg/sg mice dem-
onstrated increased expression of peroxisome proliferator-acti-
vated receptor-, coactivator 1 (PGC-1/) and lipin1 gene
expression in liver and white and brown adipose tissue. These
genes increase fatty acid utilization and oxidative metabolism.
Interestingly, the sg/sgmicedidnotaccumulate fat andwere resist-
ant to diet-induced obesity, despite hyperphagia. In summary, our
study suggests ROR is an important factor in the regulation of
genes associated with lipid homeostasis and adiposity.
MATERIALS ANDMETHODS
Animals and Tissue Collection—Heterozygous /sg mice,
B6.C3(Cg)-Rorasg/J, were obtained from Jackson laboratory
(BarHarbor,ME), and the colonywasmaintained by backcross-
ing to C57BL/6J. Identification was carried out by PCR geno-
typing as described by Jackson laboratory. The mice were
housed in Queensland Bioscience Precinct vivarium (Univer-
sity of Queensland, St. Lucia, Queensland, Australia) with a
12-h light-dark cycle and fed a standard diet containing 4.6%
total fat or a high fat diet (SF01-028) containing 22.6% fat (both
from Specialty Feeds, Glen Forrest, Western Australia).
Homozygous sg/sg mice and their wild-type (wt) littermates
were obtained by crossing heterozygous male and female
breeders. The mice were weaned at 4 weeks of age but were fed
with moist mash standard diet ad libitum as described by
Guastavino (17) in the final week prior to weaning and thereaf-
ter postweaning. High fat fed animals were similarly provided
with moist, mashed pellets and diluted, food grade strawberry
flavoring to improve palatability. Access towaterwas facilitated
by adding dishes of water and hanging gel packs (Able Scien-
tific,Welshpool,WesternAustralia) in each cage. Experimental
animalswereweighedweekly.Micewere fasted for 6 h by trans-
ferring to a new food-free holding cage with unrestricted access
to water. Blood collection was performed by terminal cardiac
puncture, under isoflurane anesthesia. Otherwise animals were
euthanized by cervical dislocation at 14 weeks of age. Tissues
collected for RNA extraction were immediately frozen in liquid
nitrogen and then stored at 80 °C. For histological examina-
tion, tissues were fixed in 10% buffered formalin (Sigma-Aldrich),
paraffin-embedded, and sections were stained with hematoxylin
andeosin.All aspectsofanimalexperimentationwereapprovedby
The University of Queensland Animal Ethics Committee.
RNA Extraction and cDNA Synthesis—Total RNA extraction
and cDNA synthesis were performed as previously described,
with minor modifications. Following homogenization with a
handheld ultra-turrax homogenizer (IKA, Staufen, Germany),
total RNA from liver and quadriceps muscles was extracted
using TRI reagent (Sigma-Aldrich) and an RNeasy mini kit
(Qiagen) according to the manufacturers’ protocol. For epidid-
ymal adipose tissue and brown adipose tissue, RNA was
extractedwithQiazol and anRNeasymini kit (Qiagen). Reverse
transcription was performed as previously described, using 1
g of total RNA in each cDNA synthesis reaction (14).
Primers and Quantitative PCR—Relative expression of
genes was determined using the ABI 7500 Real-Time PCR
System (ABI, Singapore) as previously described (14). Prim-
ers for 18S, total mROR, ABCA1, ABCA8/G1, FAS, LPL,
NOR1, NUR77, SREBP-1c, UCP2, MCAD, and CPT1b also
have been reported (14, 18, 19). ADRB1 (Mm00431701_s1),
ADRB2 (Mm02524224_s1), ADRB3 (Mm00442669_m1),
ATGL (Mm00503040_m1), HSL (Mm00495359_m1),
LIPC (Mm00433975_m1), Lipin1 (Mm00550511_m1), GcK
(Mm00439129_m1), Nurr1 (Mm00443060_m1), CPT1a
(Mm00550438_m1), PGC-1 (Mm00447183_m1), and
PGC-1 (Mm00504720_m1) TaqMan Gene Expression Assays
were obtained fromApplied Biosystems (Foster City, CA).Mus
musculus primer sequences (forward and reverse, respectively)
used for SYBR assays are as follows:mROR1, GCGCAGGCA-
GAGCTATGC and CACGTAATGACACCATAATGGATTC;
mROR4, GCGGCGTAAAGGATGTATTTTG and CCACAG-
ATCTTGCATGGAATAATT;ChREBP, GGACAAGATCCGG-
CTGAAGandGGCTTCTCGTCCGTTGCA;LXR, GAAATG-
CCAGGAGTGTCGAC and GATCTGTTCTTCTGACAGCA-
CACA; LXR, TGCAACAAACGATCTTTCTCC and TCTCG-
GGACTGAGGGTCTG; UCP1, ACAGAAGGATTGCCG-
AAAC and AGCTGATTTGCCTCTGAATG;UCP3, CTCCCC-
TAGGCAGGTACCG and CAGAAAGGAGGGCACAAATCC;
and leptin, TTCAAGCAGTGCCTATCCAGAA and GGATAC-
CGACTGCGTGTGTG. Primerswere obtained fromGeneworks
(Thebarton, South Australia).
Chromatin Immunoprecipitation—Mouse myogenic C2C12
cells were differentiated into post-mitoticmultinucleatedmyo-
tubes by incubation for 5 days in Dulbecco’s modified Eagle’s
medium (supplemented with 2% horse serum). Subsequently,
cells were washed twice in ice-cold phosphate-buffered saline
and cross-linked in 1% formaldehyde solution. Chromatin
immunoprecipitation was performed as described by Li et al.
(20) using anti-ROR antibody (sc-6062, Santa Cruz Biotech-
nology, Santa Cruz, CA). The following SREBP1c quantitative
PCR ChIP primers were used: NR1, CTCAGATGTCAGAAG-
GAGCAGAGTAG and GTTCTGTCCAGCCTGCAAGTG;
NR2, CCCCCTCCTTGAAACAAGTGT andGCAGCAAGA-
TTTGCCTACAGTCT; and glyceraldehyde-3-phosphate
dehydrogenase, GCTCACTGGCATGGCCTTCCG and GTA-
GGCCATGAGGTCCACCAC.
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Transient Transfections—Each well of a 24-well plate of
COS-1 or C2C12 cells was transfected with a total of 0.6–0.8
g of DNA per well using the liposome-mediated transfection
procedure. Cells were cotransfected with pGL3-SREBP1c lucif-
erase gene reporter (21) and either pSG5-ROR1 (22), pSG5-
ROR4 (2), or empty vector using an N-[1-(2,3-dioleoy-
loxy)propyl]-N,N,N-trimethylammonium methyl sulfate and
Metafectene (Biontex Laboratories GmbH,Munich, Germany)
liposome mixture as described previously (14). The -fold acti-
vation is expressed relative to LUC activity obtained after
cotransfection of the empty reporter and pSG5 vector only,
arbitrarily set at 1. The mean -fold activation values and stand-
ard error were derived from three independent experiments of
triplicate wells.
Blood and Tissue Analysis—High density lipoprotein choles-
terol from whole blood was measured using the Cholestech
LDX System (Hayward, CA). Measurements of total choles-
terol, triglyceride, and non-esterified fatty acid in heparinized
plasma samples were analyzed by Clinical Pathology Labora-
tory, School of Veterinary Science, The University of Queens-
land (St. Lucia, Queensland, Australia). To obtain hepatic trig-
lyceride measurements, liver tissue was saponified by digestion
with ethanolic KOH, neutralized, and then assayed using Free
Glycerol Reagent (Sigma-Aldrich).
Statistical Analysis—Data were analyzed (and significance
assigned) using the ratio t test in the GraphPad Prism 4 soft-
ware, unless otherwise indicated.
RESULTS
ROR1 and -4mRNAExpression Is Substantially Attenuated
in theMetabolic Tissues from sg/sgMice—As discussed, a num-
ber of studies have implicated ROR in the regulation of lipid
homeostasis. We were particularly interested in exploring this
further and examining the effect of functional ROR deficiency
on the regulation of critical genes involved in anabolic and cat-
abolic lipid metabolism in the major mass metabolic tissues in
sg/sgmice.
Initially, we investigated ROR1 and -4 mRNA expression
in the skeletal muscle, liver, and white adipose tissue of
homozygous sg/sg mice. We demonstrated expression of the
mRNAs encoding ROR1 and -4 was significantly attenuated
in the muscle, liver, and adipose tissues of homozygous sg/sg
mice (Fig. 1, A and B). This is concordant with previously
reported analysis of ROR expression in the cerebellum, liver,
and intestine of sg/sgmice (5, 12, 23).
Staggerer (sg/sg) Mice Display an Early Onset (20%)
Decrease in Weight That Is Maintained after Maturity and
Revealed Reduced Adiposity—Interestingly, as discussed in a
very recent report (24), no detailed data (over many weeks) on
the specific changes in body weight in sg/sg mice have been
reported (relative to wild-type littermates), despite hyperpha-
gia on a regular chow diet (16). Crucially, our mice were fed a
“pasty mix” of crushed food moistened with water and placed
on the floor of the cage. Water is supplied in a small dish, and
accessible gel packs are provided in each cage. This circumvents
any issues associated with access to food due to stretching dif-
ficulties in sg/sgmice that effects mortality (17). Subsequently,
we ascertained the growth pattern ofmale sg/sgmice from age 4
weeks to maturity at 14 weeks on a normal chow diet.
At weaning, the sg/sg mice are 50% smaller than their wt
counterparts. As theymature the size difference lessens, and by
adulthood male sg/sg mice maintain a body mass that is 15–
20% decreased relative to wt mice (Figs. 2, A and B). The sg/sg
mice displayed reduced adiposity (Fig. 2C). Interestingly, the
size of the epididymal white adipose depots (corrected for total
bodyweight) weremarkedly and significantly decreased in sg/sg
mice (Fig. 2D). This correlated with a substantial reduction in
adipocyte cell size (Fig. 2E). No significant differences were
observed in the heart, quadriceps, and gastrocnemius skeletal
muscle tissues, however, a small, but significant decrease in
liver weight was observed (Fig. 2D).
Decreased Plasma Cholesterol Is Associated with Decreased
Expression of mRNAs Encoding the Reverse Cholesterol Trans-
porters ABCA and ABCA8/G1 in the Liver—Mamontova et al.
(11) previously reported decreased serum cholesterol in sg/sg
mice that is associated with decreased apoA1 expression in the
intestine (not the liver). We similarly observed plasma (total
andHDL) cholesterol were decreased in the serumof sg/sgmice
on a normal chow diet (Fig. 3, A and B). We utilized candidate-
based expression profiling of the liver, and examined several
additional genes (and pathways) that could potentially account
for reduced plasma cholesterol. We identified significantly
reduced expression of themRNAs encoding the reverse choles-
terol transporters, ABCA1, and ABCA8/G1 in the liver of sg/sg
mice (Fig. 3, C and D). Many studies have reported the link
between impaired hepatic reverse cholesterol transport and
HDL cholesterol.
Decreased Serum and Liver Triglycerides in sg/sg Mice Are
Mediated by Decreased SREBP-1c and FAS mRNA Expression
in the Liver—Raspe et al. (13) demonstrated reduced plasma
triglycerides in female sg/sg mice that was associated with
reduced apoCIII expression in the liver. Analysis of male sg/sg
mice revealed that triglycerides (and non-esterified fatty acids)
were decreased (Fig. 4,A and B). Additionally, we examined the
total triglyceride content and concentration of the liver. We
report that total triglyceride content and the concentration
(milligrams/g liver wet weight) are significantly reduced in the
hepatic tissue from sg/sgmice, relative to wild-type littermates
(Fig. 4C). This is consistentwith decreased plasma triglycerides.
Subsequently, we utilized candidate-based profiling and
examined several genes involved in lipogenesis to identify the
FIGURE 1. Reduced gene expression of ROR isoforms in male staggerer
sg/sgmice.QuantitativePCRof theROR1 isoform (A) and theROR4 isoform
(B)mRNA levels in quadriceps skeletalmuscle, liver, and epididymal fat pad in
malewt and sg/sgmice (each n 4). RelativemRNA expression is normalized
against 18S rRNA. Results are expressed as the mean S.E. ***, p 0.001.
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underlying changes in gene expression responsible for the dys-
lipidemia. SREBP-1c is an important hierarchical regulator of
lipogenesis (25, 26). Changes in SREBP-1c (and target gene
expression) in liver, adipose, and muscle are associated with
changes in plasma triglycerides (25, 27). Interestingly, we
observed significantly reduced expression of themRNA encod-
ing SREBP-1c (Fig. 4D) and the lipogenic enzyme, FAS (Fig. 4E)
in the liver, and/or skeletal muscle of sg/sgmice, relative to the
littermate wt controls. This is concordant with the observed
(and reported) reduction in plasma triglycerides from sg/sg
mice (13). In this context, as discussed above, we also observed
FIGURE 2. Reduced body weight, fat, liver weight, and adiposity in male
staggerer sg/sg mice. A, photograph showing reduced body size in sg/sg
mouse; B, body weight development in sg/sg versus wt littermate controls
over 14 weeks (each n  10–22). C, photographs showing reduced body
fat pads in sg/sg mice (right panel) with its wt littermate (left panel) at 14
weeks. D, tissue weights of heart, quadriceps muscle, epididymal fat pad,
gastrocnemius muscle, and liver of wt and sg/sg mice (each n  8). Inset:
photograph of epididymal fat pad of wt and sg/sg mice. Tissue weights are
normalized against body weights. Results are expressed as the mean  S.E.
Data were analyzed by one-way analysis of variance with the post-hoc New-
man-Keuls multiple comparison test. *, p  0.05 and ***, p  0.001. E, pho-
tomicrographs of sg/sg mice and wt littermate epididymal fat pad stained
with hematoxylin and eosin.
FIGURE3.Plasmacholesterol, HDL, andABCA1geneexpression in liver of
male sg/sg and wt control mice. Analysis of plasma total cholesterol (each
n  4) (A) and HDL from whole blood (each n  6) (B). Quantitative PCR of
ABCA1 (C) and ABCA8/G1 (D) mRNA levels in liver of male wt and sg/sg mice.
Relative mRNA expression is normalized against 18S rRNA. Results are
expressed as the mean S.E. *, p 0.05.
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reduced expression of the mRNA encoding ABCG1 in the liver
of sg/sg mice (Fig. 3D), that is also consistent with reduced
serum triglycerides and adiposity in the sg/sg mice. A very
recent report (28), on the ablation ofABCG1 inmice, identified
an unexpected role in adiposity and triglyceride storage.
Furthermore, in the context of decreased SREBP-1c expres-
sion and downstream target genes, we examined the expression
of themRNA encoding glucokinase in fasted liver and observed
significantly reduced expression of GcK mRNA expression in
sg/sgmice (Fig. 4F). In summary, decreased SREBP-1c and FAS
mRNA expression observed in sg/sg mice account for the
decreased serum (and liver) triglycerides and reduced
adiposity.
ROR Regulates the SREBP-1c Promoter—Liver X receptors
(LXRs) and carbohydrate response element-binding protein
(ChREBP) (29, 30) are critical transcriptional regulators of
SREBP-1c, lipogenic gene expression, and fatty acid biosynthe-
sis. Hence, we investigated the expression of LXR (LXR and
LXR) and ChREBP in sg/sg mice. We did not detect major
changes in the expression of these transcription factors, in the
hepatic tissue of sg/sg, relative to wild-type mice (Fig. 4, G–I).
The change in LXR attained significance, however, the
decrease in expression was very small. This suggested that the
lower triglyceride levels in the liver and plasma were primarily
the result of decreased SREBP-1c expression.
SREBP-1c expression is also regulated by insulin, repressed
upon fasting, and tightly linked to the nutritional state (31–33).
To date, C. Ron Kahn and colleagues (34) have recently stated
“how these two factors (LXR and insulin) interact in the control
of SREBP-1c remains a subject of debate” (35–37). In this con-
text, we have observed in the fed versus (6 h) fasted transition
that SREBP-1cmRNA expression is very similarly decreased in
wt and sg/sgmice (data not shown).
This raised the question as to whether dysfunctional ROR
expression is responsible for aberrant SREBP-1c expression in
sg/sgmice. ChIP analysis (quantitated by real-time PCR ampli-
fication) in muscle cells demonstrated that ROR was effi-
ciently and preferentially recruited to two upstream regions,
NR1, between nucleotide positions 1342/1158 and NR2
between nucleotide positions 481/458 in the SREBP-1c
promoter relative to the GAPDH promoter (see Fig. 5, A–C).
This suggested that RORmay regulate the expression of the
SREBP-1c promoter. Transfection analysis demonstrated that
ROR1 and -4 trans-activated the SREBP-1c (1200/103)
promoter in COS-1 (Fig. 5D) and C2C12 skeletal muscle cells
(Fig. 5E).
The SREBP-1c (1200/103) promoter contained the NR2
region, the primary ROR recruitment site. However, our ChIP
assay identified secondary recruitment of ROR to a region
between nucleotides 1342 and 1158 (which contains three
well conserved RGGTCA NR half-sites) (Fig. 5B) and was not
FIGURE 4.Plasma lipids and gene expression in liver ofmale sg/sg andwt
control mice. Analysis of plasma triglyceride (each n 4) (A) and non-ester-
ified fatty acid (each n 4) (B) of male wt and sg/sgmice. C, measurement of
total triglyceride content and triglyceride concentration in liver of male wt
and sg/sgmice (n7–8). Quantitative PCRof (D) SREBP1cmRNA levels in liver
andquadricepsmuscle ofmalewt and sg/sgmice (n 7–8). Quantitative PCR
of FAS (E), GcK (F), LXR (G), LXR (H), and ChREBP (I) mRNA levels in liver of
male wt and sg/sg mice (n  7–8). Relative mRNA expression is normalized
against 18 S rRNA. Results are expressed as themean S.E. *, p 0.05; **, p
0.01; and ***, p 0.001.
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present in our SREBP-1c reporter. Hence, we subsequently
cloned a single copy of the promoter region between 1342
and1158 into the TK-luc basal promoter to examinewhether
this fragment supported ROR-mediated transcription. Inter-
estingly, this region is selectively trans-activated by ROR4. In
summary, this demonstrated ROR was directly recruited to,
and modulated the activity of the SREBP-1c promoter.
PGC-1 and Lipin1 mRNA Expression Are Significantly
Increased in the Liver and White and Brown Adipose Tissue of
sg/sg Mice—We further explored underlying changes in gene
expression (in addition to decreased SREBP-1c) that may
account for reduced adiposity. Hence, we utilized candidate-
based expression profiling to examine whether the expression
of genes that regulate fatty acid oxidation (and oxidativemetab-
olism) are modulated in sg/sgmice.
PGC-1 and -1 are important regulators of fatty acid oxi-
dation and oxidative metabolism (38). We observed that the
expression of the mRNA encoding PGC-1 is increased in liver
and white adipose tissue (but not in brown adipose tissue or
skeletal muscle) of fasted sg/sgmice, relative to littermate con-
trol wt mice (Fig. 6, A, D, G, and J). However, the increase in
white adipose tissue just failed to attain statistical significance
(p 0.051). PGC-1 induces the gluconeogenic program in the
liver (38). Therefore, we investigated the levels of PEPCK (as an
indicator of functional PGC-1 induction). In agreement with
elevatedPGC-1 expression, we observed significantly elevated
levels of PEPCKmRNA in the liver of fasted sg/sgmice (relative
to the littermate control, wt mice) (data not shown).
Subsequently, we examined
PGC-1 expression in liver, white
and brown adipose, and skeletal
muscle tissue. Speigelman and col-
leagues (39, 40) have demonstrated
PGC-1 induces the formation of
oxidative (mitochondrial rich) mus-
cle fibers and brown adipose tissue.
We observed significantly elevated
levels of PGC-1 mRNA in brown
adipose tissue (Fig. 6H) (but not in
liver, white adipose tissue, and skel-
etal muscle) of sg/sgmice relative to
the littermate control wt mice (Fig.
6, B, E, and K).
Moreover, we examined lipin1
expression in liver, white and brown
adipose, and skeletal muscle tissue.
Finck et al. (41) have demonstrated
that PGC-1 induces lipin1 expres-
sion in hepatic tissue and demon-
strated that lipin1 selectively acti-
vates a subset of fatty acid oxidation
pathways, while repressing lipogen-
esis and plasma lipids. We observed
significantly elevated levels of lipin1
mRNA in liver andwhite and brown
adipose tissue (but not in skeletal
muscle) of sg/sgmice relative to the
littermate control wtmice (Fig. 6,C,
F, I, and L). The changes in lipin1 are in concordance with
significantly increased PGC-1 expression, reduced lipogenic
gene expression, and decreased (serum and liver) triglycerides.
In summary, we observed significantly increased expression of
genes involved in the regulation/activation of fatty acid oxida-
tion (and oxidative metabolism), that coupled to suppressed
SREBP-1cmRNA expression may account for reduced adipos-
ity in the sg/sgmice.
In addition, we examined the expression of genes directly
involved in the fatty acid oxidation pathway (e.g. CPT-1a/b and
MCAD) in liver, white adipose tissue, and skeletal muscle
(Table 1).Weobserved that the expression ofCPT1a and -bwas
not significantly different between wt and staggerer littermate
mice. However, we observed a significant1.5-fold increase in
MCADmRNA expression in white adipose (but not in liver or
skeletal muscle) tissue (Table 1). It should be noted that it has
been reported that “increased flux of fatty acids through the
-oxidation pathway does not necessarily require marked
changes in expression of genes involved in metabolism” (42).
2-Adrenergic Receptor mRNA Expression Is Significantly
Increased in Brown Adipose Tissue—We also explored whether
the reduced adiposity involved sympathetic regulation of lipid
metabolism. We examined the expression of the 1-, 2-, and
3-adrenergic receptors (1–3-AR/ADRB1–3) in liver, white
and brown adipose, and skeletal muscle tissue. We did not
observe any significant increases in the expression of these
adrenergic receptors in liver, white adipose, and muscle tissue
(Fig. 7, A–C). However, we did observe a small but significant
FIGURE 5. Binding and transactivation of SREBP1c gene promoter by ROR. A and B, diagrammatic repre-
sentation of nuclear receptor response elements onmouse SREBP1cpromoter investigated in this study. C, the
recruitment of ROR onto SREBP1c nuclear receptor response elements in muscle C2C12 cells by ChIP assay
(representative assay). Results are expressed as the mean  S.D. D, transient transfection of mouse pGL3-
SREBP1c gene reporter with pSG5-ROR1 or pSG5-ROR4 or pSG5 vector in COS-1 cells. Results are expressed
as the mean -fold activation S.E. (n 3). *, p 0.05. E, transient transfection of mouse pGL3-SREBP1c gene
reporter with pSG5-ROR1 or pSG5-ROR4 or pSG5 vector in skeletal muscle C2C12 cells. F, transient transfec-
tion ofmouse pTK-LUC-SREBP1c(1342/1158) reporter with pSG5-ROR1 or pSG5-ROR4 or pSG5 vector in
skeletal muscle C2C12 cells. Results are expressed as themean S.E. (n 3). *, p 0.05; **, p 0.01. The -fold
activity of pGL3basic or pTK-LUC cotransfected with pSG5 is arbitrarily set to 1.
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decrease in 3-AR (ADRB3) expression in the white adipose
tissue from sg/sgmice, relative to wt littermates.We observed a
significant (3- to 4-fold) increase in 2-AR (ADRB2) expression
in the brown adipose tissue from sg/sgmice.
FIGURE 6. Analysis of PGC-1, PGC-1, and lipin1 mRNA expression in
liver, epididymal (white) fat pad, brown (interscapular) fat, and quadri-
ceps muscle. Quantitative PCR of PGC-1 in liver (A), white adipose (D),
brown adipose (G), and skeletal muscle (J) tissue, respectively, and PGC-1
mRNA levels in liver (B), white adipose (E), brown adipose (H), and skeletal
muscle (K) tissue, respectively, of male wt and sg/sgmice. Lipin1mRNA levels
in liver (C), white adipose (F), brown adipose (I), and skeletal muscle (L) tissue,
respectively, of male wt and sg/sgmice. RelativemRNA expression is normal-
ized against 18 S rRNA. Results are expressed as the mean  S.E. (n  7–8).
*, p 0.05 and **, p 0.01.
FIGURE7.Analysisof-ARsandNR4AmRNAexpressioninmalewtandsg/sg
mice.Quantitative PCRofADRB1 (A),ADRB2 (B),ADRB3 (C),NUR77 (D),NURR1 (E),
andNOR-1 (F) in liver, epididymal (white) and interscapular (brown) fat pads, and
quadriceps muscle. Relative mRNA expression is normalized against 18 S rRNA.
Results are expressed as themean S.E. (n 7–8). **, p 0.01.
TABLE 1
Analysis of CPT1a, CPT1b, andMCADmRNA expression in liver, white
adipose and skeletal muscle of male wt and sg/sgmice
RelativemRNAexpression is normalized against 18S rRNA. Results are expressed as
the mean S.E. (n 7–8).
WT sg/sg
Liver
CPT1a 1.98 104 2.13 105 2.13 104 2.68 105
MCAD 2.97 105 1.92 106 3.04 105 2.06 106
White adipose
CPT1a 6.22 105 6.93 106 5.04 105 6.27 106
MCADa 1.37 104 5.97 106 1.94 104 2.08 105
Skeletal muscle
CPT1b 4.65 105 5.17 106 4.20 105 5.73 106
MCAD 2.52 105 2.42 106 2.29 105 2.75 106
a p 0.05.
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Furthermore, adrenergic signaling has been demonstrated to
induce the expression of the nuclear receptor subfamily 4,
group A (NR4A) subgroup of nuclear receptors that regulate
metabolism (18, 19, 43–45). Hence, we examined the expres-
sion of theseNRs.We did not observe significant changes in the
expression of NR4A1–3 in the liver, adipose, and skeletal mus-
cle tissues (Fig. 7, D–F). However, we observed 2- to 3-fold
increases in NOR-1 in white and brown adipose in staggerer
mice, but these changes did not attain significance (p  0.12
and 0.2, respectively).
The increased 2-AR (and NOR-1) expression in the brown
adipose tissue from staggerer mice is consistent with the
30–70%highermetabolic rate (depending on temperature) and
the increased levels of endogenous norepinephrine in (cold
reared) staggerermice relative to control mice (15, 46).
Reduced Adiposity Does Not Involve Changes in Gene Expres-
sion (IncludingNuclearHormoneReceptors) ThatControl Lipid
Mobilization in Liver, Adipose, and Muscle Tissue—Interest-
ingly, the decreased adiposemass and adipocyte cell size did not
correlate with increased lipid mobilization. Staggerer mice,
expressed similar levels of lipoprotein lipase (LPL), adipose
triglyceride lipase (ATGL), hormone-sensitive, and lipase C
(hepatic lipase, LIPC) relative to wild littermate mice (Figs. 8,
A–D) in liver, white adipose, and skeletalmuscle tissue. In addi-
tion, we examined the expression of the uncoupling protein
genes (UCP1–3) that regulate energy expenditure (and lipid
utilization). Expression in the liver, adipose, and skeletalmuscle
tissue from wt and sg/sg mice was essentially similar (Fig. 8,
E–G). However, the expression ofUCP-3 (involved in preferen-
tial free fatty acid utilization in rodent and human skeletalmus-
cle (47, 48)) mRNA was increased (but did not attain signifi-
cance, p  0.2) in skeletal muscle from sg/sg mice (Fig. 8F).
Moreover, increased expression (that did not attain signifi-
cance, p 0.09) ofUCP-1 in brown adipose was also observed,
and this correlated with the increases in NOR-1 expression in
this tissue (Fig. 8G). Sheila Collins and colleagues very recently
reported the NOR-1-dependent induction of UCP-1 (46).
Finally, we examined a panel of nuclear receptors that are
known to function as master regulators of lipid and cholesterol
homeostasis. The expression of LXR and -, estrogen-related
receptor (ERR) /, and peroxisome proliferator-activated
receptor (PPAR) , /, and  was similar in liver and adipose
tissue from sg/sg and wt mice (data not shown).
In summary, the staggerer phenotype is characterized by
underlying changes in gene expression that regulate lipogenic
and oxidative metabolism. However, we did not observe
changes in expression of genes that control lipid mobilization
and energy expenditure. Neither did we observe changes in the
expression of nuclear receptors (NRs) that are master regula-
tors of lipid homeostasis.
Staggerer Mice Are Resistant to Diet-induced Obesity—We
subsequently examined the physiological response of staggerer
mice to an energy dense (high fat) diet.
Male and female wild-type and sg/sg mice were placed on
standard and high fat diets for a 10-week period. Interestingly,
male and female sg/sg mice are completely resistant to diet-
induced weight gain and obesity. For example, no significant
differences in the weight of male and female sg/sg mice were
observed over a 10-week period on a regular chow diet (10%
of total calories from fat) comparedwith those on a high fat diet
(40% of energy from fat). In contrast, the male and female wt
mice, experience increases of 17% (Fig. 9, A and C) and 22%
(Fig. 9B) in weight, respectively, after 10 weeks on the high fat
relative to the regular diet.
This was underscored by increased adiposity (Fig. 9D) and
significantly increased amounts of epididymal and inguinal
white adipose (Fig. 9E) in the wt, relative to male sg/sgmice (on
the standard diet). Furthermore, this difference in the epididy-
mal and inguinal fat depots was highly significant andmarkedly
amplified in the wtmice after 10 weeks on the high fat diet (Fig.
9E). In addition, significantly increased amounts of brown adi-
pose (interscapular fat) inwtmice (relative to the sg/sg) was also
observed in male mice on the high fat diet (Fig. 9G). This cor-
relates with increased adipocyte cell size in brown adipose from
wt versus sg/sgmice (Fig. 9H). Similarly, increased ovarian and
inguinal fat depots in wt mice (relative to the sg/sg) were also
observed in females on the high fat diet (Fig. 9F). In contrast, no
significant differences in corrected heart and liver tissue
weights (from male wt and sg/sgmice) were observed (Fig. 9E)
on the chow (standard) and/or high fat diets. Notably, analysis
of sg/sgmice revealed the distinct lack of fat accumulation in the
gonadal and inguinal adipose in the sg/sg mice (relative to the
wild-type mice) on the high fat diet. Moreover, the white adi-
pose fat pad sizes in sg/sgmicewere similar on the regular chow
and high fat diets (Fig. 9E).
Interestingly, in the context ofwhere the fatwas being depos-
ited, we also analyzed hepatic triglyceride levels frommale and
female wt and sg/sgmice on the high fat diet.We report that the
triglyceride concentrations (milligrams/g liver wet weight) are
FIGURE 8. Examination of gene expression regulating lipid mobilization
andenergyexpenditure. Expressionprofilingof themRNAs encodingATGL,
HSL, LPL, LIPC, and UCP1–3 in liver, white and brown adipose, and skeletal
muscle. Quantitative PCR ofmRNA levels of LPL (A), ATGL (B),HSL (C), and LIPC
(D), in liver, epididymal fat pad, and quadriceps muscle of male wt and sg/sg
mice (n  7–8), and UCP1 (E), UCP2 (F), and UCP3 (G) in liver, epididymal
(white) and interscapular (brown) fat pads, and quadricepsmuscle ofmalewt
and sg/sgmice (n7–8). RelativemRNAexpression is normalizedagainst18S
rRNA. Results are expressed as the mean S.E. (n 7–8).
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significantly lower in the hepatic tissue from male and female
sg/sgmice, relative to wild-type littermates (Fig. 9, I and J).
Furthermore, to examine whether resistance to diet-induced
obesity, and the distinct lack of fat accumulation in the adipose
(and liver) from sg/sg mice (on a high fat diet) involved hypo-
phagia, we measured food intake. Guastavino et al. (16) dem-
onstrated that staggerermice are hyperphagic on a regular chow
diet. We measured the food intake of male sg/sg and wt litter-
mates on the high fat diet, and in concordance with the study
above, but surprisingly, we observed that staggerer mice con-
sumed double the amount of food relative to their wild-type
littermates, and this translated to 3-fold increase in food
intake per gram of body weight (milligrams/gram of animal)
(see Fig. 9K). Moreover, this correlated with significantly
decreased leptin expression in white adipose tissue (Fig. 9L).
In summary, analysis of sg/sgmice revealed the striking lack
of lipid accumulation in the adipose (and liver) from the sg/sg
mice (relative to thewild-typemice) on the high fat diet, despite
hyperphagia.
DISCUSSION
Two isoforms of ROR are expressed in mice (1 and 4)
(49). Using quantitative PCR analysis, we showed that the
mRNA encoding ROR4 is the predominantly expressed iso-
form in liver, white adipose, and skeletal muscle tissue. How-
ever, expression of both the ROR1 and -4 transcripts was
diminished in sg/sgmice.
Our results indicated that sg/sgmice have a complex pheno-
type with lower body weight, reduced adiposity, decreased
plasma cholesterol, non-esterified fatty acid, and reduced trig-
lycerides (in the serum and liver) and are refractory to diet-
induced obesity.
As discussed, Staels et al. (11) have reported an association
between decreased HDL-c and intestinal ApoAI production in
sg/sg mice. Here we demonstrate that these mice also exhibit
decreased expression of the reverse cholesterol transporters,
ABCA1, and ABCA8/G1 in the liver. Studies that utilize a liver-
specific knock-out of ABCA1 have established a crucial role for
this transporter in HDL biosynthesis (51). Hence, sg/sg mice
exhibit impaired HDL biosynthesis as a result of decreased
expression of ABCA1.
We have also observed a reduction in liver (and plasma) trig-
lycerides in sg/sg mice compared with normal wt littermates.
FIGURE 9. Tissue and body weight gain in wt and sg/sgmice on high fat
diet.Comparison of bodyweight gain ofmale (A) and female (B) wt and sg/sg
mice on normal chow diet (Chow) and high fat diet (HFD) (n 6–20). C, pho-
tograph showing reduced body size in male sg/sg mice on HFD;
D, photographs showing reduced body fat pads in male sg/sg mice (right
panel)with itswt littermate (left panel) at 14weeksonHFD.E, tissueweightsof
epididymal fat pad, inguinal fat pad, heart, and liver ofmalewt and sg/sgmice
on chow and HFD. Data were analyzed by one-way analysis of variance with
post-hoc Newman-Keuls multiple comparison test (n  5–8). F, tissue
weights of ovarian fat pad, inguinal fat pad of female wt, and sg/sg mice on
HFD. Datawere analyzedby one-way analysis of variancewith post-hocNew-
man-Keulsmultiple comparison test (n5).G, tissueweights of interscapular
brown fat pads frommale wt and sg/sgmice on HFD, (n 5). H, photomicro-
graphs showing interscapular fat pads of sg/sg mice and wt littermates on
HFD stainedwith hematoxylin and eosin. I and J, measurement of triglyceride
concentration in liver of male and female wt and sg/sgmice on a high fat diet
(n 7–10), respectively. K, measurement of total corrected daily food intake
in male wt and sg/sg mice on HFD (n  4 wt, n  3 sg/sg); L, expression
profiling of the mRNA encoding leptin in white adipose (epididymal fat pad)
frommalewt and sg/sgmice (n 7–8) on a chowandHFD (n 7–8). Relative
mRNA expression is normalized against 18S rRNA. All results are expressed as
the mean S.E. ***, p 0.001;**, p 0.01; and *, p 0.05.
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The mechanism involves suppression of the transcriptional
regulator, SREBP-1c, and suppression of the lipogenic gene
program is responsible for this phenotype. For example, sg/sg
mice expressed significantly reduced levels of the mRNAs
encoding SREBP1c, FAS, and ABCG1.
SREBP-1 is a critical transcription regulator that controls the
expression of genes involved in fatty acid biosynthesis and the
nutrition-dependent induction of lipogenesis (52). SREBP-1c
directly regulates the lipogenic enzymes, including FAS, by
selectively binding to the target promoters, however, FAS can
also be regulated by SREBP-1c-independent mechanisms that
involve trans-activation by LXR (53). Mice treated with the
LXR agonist, T0901370, display hypertriglyceridemia and ele-
vated hepatic expression of the mRNAs encoding SREBP-1c
and FAS. Analogously, suppression of FAS lowers serum tria-
cylglycerol levels (54). Our observation in the sg/sg mice (of
reduced SREBP-1c and FAS expression) is concordant with
these reports. In addition, we observed significantly decreased
hepatic ABCG1 expression. This is entirely consistent with a
recent study that demonstrated ablation of this ATP-binding
cholesterol transporter reduced body weight gain, adiposity
(and adipocyte size), and serum triglycerides, all features of the
staggerer line (28).
We investigated the link between dysfunctional ROR and
decreased lipogenic gene expression and reduced triglycerides.
SREBP-1c (and its downstream target FAS) are well character-
ized LXR target genes. LXR regulates hepatic lipogenesis.
Moreover, it modulates ChREBP expression, a direct regulator
of lipid synthesis. ChREBP consequently regulates FAS and the
enzymes that channel the glycolytic end-products into lipogen-
esis (for example, pyruvate kinase-liver type) (29, 30). Hence,
LXR (denotedmaster lipogenic factor) and ChREBP are impor-
tant transcriptional regulators of hepatic lipogenesis (in con-
cert with SREBP-1c). Consequently, we examined the expres-
sion of LXR (LXR and LXR) and ChREBP in sg/sg mice.
Interestingly, we did not observe any significant changes in the
expression of these critical regulators, in the hepatic tissue of
staggerer, relative to wild-type mice (Fig. 4, F–H). This sug-
gested that the aberrant triglyceride levels in the liver and
plasma were primarily the result of attenuated SREBP-1c
expression. Furthermore, ROR transfection and ChIP studies
suggested that dysfunctional ROR expression is involved in
attenuated SREBP-1c expression.
The increased expression of PGC-1/ and lipin1 (regula-
tors of oxidative metabolism) in the liver and white and brown
adipose tissue of the sg/sg mice is consistent with the reduced
adiposity of the sg/sg mice reported here. For example, in diet
and geneticmediatedmousemodels of obesity (55), the expres-
sion of PGC-1, a cellular regulator of oxidative metabolism
and energy production (Ref. 56 and references therein) is
diminished. Likewise, lipin1 expression is decreased in obesity
and elevated by weight reduction (57).
In addition, further analysis of brown adipose tissue revealed
significantly increased 2-ARmRNA expression in brown adi-
pose tissue from staggerer mice (relative to the wt littermate).
This was coupled to 2- to 3-fold increases inNOR-1 andUCP-1
in this tissue. These observations are consistent with previous
reports that demonstrated 30–70% higher metabolic rate
(depending on temperature) and higher endogenous levels of
norepinephrine in (cold reared) sg/sg mice relative to control
mice (15). However, norepinephrine treatment results in simi-
lar increases in oxygen consumption in sg/sg and control mice.
Furthermore, adrenergic signaling regulates lipolysis (58) and
has been demonstrated to induce the expression of the NR4A
subgroup of nuclear receptors that regulate metabolism in
muscle, adipose, and liver (18, 19, 43–46, 58–60).
Subsequently, we investigated the response of the sg/sgmice
to a metabolic challenge involving an energy dense (high fat)
feeding regime. Both male and female sg/sg mice were com-
pletely refractory to fat accumulation and diet-induced obesity.
This was underscored by dramatic increases in white and
brown adipose depots, and hepatic triglycerides in wild-type
mice, but not in sg/sgmice after a period of 10 weeks on a high
fat diet. This demonstrates ROR operates as an important
modulator of lipid homeostasis in liver and white and brown
adipose tissue.
Our report demonstrates the lean phenotype in sg/sgmice is
characterized by significantly decreased SREBP-1c (and lipo-
genic gene) expression and increased expression of PGC-1/,
lipin1, and 2-AR expression in liver, muscle, and (white and
brown) adipose tissue. This is concordant with the previously
reported increased metabolic rate/O2 consumption and higher
endogenous epinephrine levels in brown adipose from staggerer
mice. These observations, coupled to increased expression of
genes controlling oxidative metabolism and decreased expres-
sion of genes involved in lipid deposition, provide molecular
explanations for reduced adiposity and hepatic triglycerides in
staggerer mice. These factors provide molecular evidence for
the resistance to diet-induced obesity, despite hyperphagia
(which correlated to reduced leptin expression in adipose tis-
sue) (17, 50, 61).
In conclusion, we suggest this orphan NR operates as an
important modulator of the equilibrium between anabolic and
catabolic lipid metabolism in hepatic and peripheral metabolic
tissues. The link between dysfunctional ROR and protec-
tion against obesity suggests this orphan NR may have
potential utility in the treatment of metabolic disease. The
challenge for the future is the identification of organ-specific
selective modulators/antagonists.
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